Agreement between cerebrospinal fluid biomarkers, brain 18-Fluorodeoxyglucose PET, and clinical diagnosis in older adults with cognitive impairment
Background: Clinical practice has advanced toward a combined diagnostic approach that involves clinical criteria and biological markers for Alzheimer's disease (AD) and other dementias. Objective: To establish the level of diagnostic agreement between an initial clinical diagnosis and cerebrosp...
Saved in:
Main Authors: | Alberto J. Mimenza-Alvarado (Author), Karen G. León- (Author), Rodrigo Hernández-Ramírez (Author), Juan de D. Rodríguez-Callejas (Author), Sara G. Yeverino-Castro (Author), Sara G. Aguilar-Navarro (Author) |
---|---|
Format: | Book |
Published: |
Permanyer,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome
by: L. Alix, et al.
Published: (2019) -
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma
by: Hiroaki Takagi, et al.
Published: (2018) -
Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease
by: Carolina A. Magalhães, et al.
Published: (2015) -
Cerebrospinal fluid biomarkers in various pediatric neurologic diseases
by: Jeongho Lee
Published: (2022) -
Synthesis and application of (18F) fluorodeoxyglucose in oncology diagnosis
by: Mateusz Wędrowski, et al.
Published: (2017)